European Heart Journal Advance Access published online on February 4, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi125
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Duke Thrombosis Center, Duke University Medical Center, Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27715, USA
* To whom correspondence should be addressed.
Editorial
The investigation of biomarkers in cardiovascular disease: time for a coordinated, international effort
Richard C. Becker, E-mail: becke021{at}mc.duke.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. C. Gilbert, T. DeFeo-Fraulini, R. M. Hutabarat, C. J. Horvath, P. G. Merlino, H. N. Marsh, J. M. Healy, S. BouFakhreddine, T. V. Holohan, and R. G. Schaub First-in-Human Evaluation of Anti von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers Circulation, December 4, 2007; 116(23): 2678 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Becker Emerging Paradigms, Platforms, and Unifying Themes in Biomarker Science J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1777 - 1780. [Full Text] [PDF] |
||||

